Angiex, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors (NCT06440005) | Angiex, Inc. | 2024-07-22 |
Track Angiex, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.